Bristol-Myers Squibb (BMY) Tops Q3 EPS by 26c, Beats on Revenue; Offers FY26 Guidance
Go back to Bristol-Myers Squibb (BMY) Tops Q3 EPS by 26c, Beats on Revenue; Offers FY26 Guidance| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.48 +1.09 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.39 | 52 Week High | $77.12 | |||
| Open | $63.00 | 52 Week Low | $49.03 | |||
| Day High | $64.05 | P/E | 40.57 | |||
| Day Low | $62.29 | EPS | $1.54 | |||
| Volume | 12,668,084 | |||||



